Copenhagen
Denmark
World Health Organization (WHO) - World Health Organization Regional Office for Europe
Multidrug-resistance, Tuberculosis, Europe, Bedaquiline, Modified short treatment regimen, Rifampicin-resistance
Tuberculosis, drug-resistance, treatment effectivness, operational research, shorter regimens
Operational research, shortened treatment, toxicity, bedaquiline, linezolid, levofloxacin